About
Facilitating early-stage, pre-clinical drug discovery research with a product portfolio…
Activity
-
#Immunity | #TherapeuticAntibodies | "Time to Count the Carbs" 👍 | The Importance of #IgG #Glycosylation | Jasminka Krištić & Gordan Lauc survey the…
#Immunity | #TherapeuticAntibodies | "Time to Count the Carbs" 👍 | The Importance of #IgG #Glycosylation | Jasminka Krištić & Gordan Lauc survey the…
Liked by Megan Conlon, PhD
-
Happy Friday all! Check out this open access Nature Comm article by Sauvé et al., "Activation of parkin by a molecular glue." Abstract: Mutations…
Happy Friday all! Check out this open access Nature Comm article by Sauvé et al., "Activation of parkin by a molecular glue." Abstract: Mutations…
Shared by Megan Conlon, PhD
-
Check out how our PDE (phosphodiesterase) enzymes were used to discover PDE11A4 Inhibitors for Age-Related Cognitive Decline:…
Check out how our PDE (phosphodiesterase) enzymes were used to discover PDE11A4 Inhibitors for Age-Related Cognitive Decline:…
Liked by Megan Conlon, PhD
Experience
Education
More activity by Megan
-
Happy Thursday all! Check out this open access Cancer Immunology, Immunotherapy review by Toledo-Stuardo, et al., "Therapeutic antibodies in…
Happy Thursday all! Check out this open access Cancer Immunology, Immunotherapy review by Toledo-Stuardo, et al., "Therapeutic antibodies in…
Shared by Megan Conlon, PhD
-
Happy Wednesday all! Check out this open access Cell Death Discovery review by Yan Zhong & Jingfeng Liu, "Emerging roles of CAR-NK cell therapies in…
Happy Wednesday all! Check out this open access Cell Death Discovery review by Yan Zhong & Jingfeng Liu, "Emerging roles of CAR-NK cell therapies in…
Shared by Megan Conlon, PhD
-
Therapeutic options for autoimmune and inflammatory diseases are steadily improving, with researchers developing targeted treatments to restore…
Therapeutic options for autoimmune and inflammatory diseases are steadily improving, with researchers developing targeted treatments to restore…
Liked by Megan Conlon, PhD
-
TIL the end: Tracking T cell clonotype dynamics during Adoptive Cell Therapy | Expert Preview* by Anthony Buzzai & Thomas Tüting at Cell Press…
TIL the end: Tracking T cell clonotype dynamics during Adoptive Cell Therapy | Expert Preview* by Anthony Buzzai & Thomas Tüting at Cell Press…
Liked by Megan Conlon, PhD
-
Happy Tuesday all! Check out this exciting Nature Biotech news article by Charlotte Harrison about the FDA's approval for "Adaptimmune’s Tecelra…
Happy Tuesday all! Check out this exciting Nature Biotech news article by Charlotte Harrison about the FDA's approval for "Adaptimmune’s Tecelra…
Shared by Megan Conlon, PhD
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More